CLS B — Clinical Laserthermia Systems AB Share News
0.000.00%
Last trade - 00:00- SEK109.86m
- SEK93.54m
- SEK17.49m
Brief: Clinical Laserthermia Systems Q1 Pre-tax Loss Narrows To SEK 9.5 Mln
Brief: CLS Announces Oversubscribed Rights Issue
Brief: CLS Recalls Its Sterile Disposable Instruments After New Information
Brief: Clinical Laserthermia Systems Gets FDA Approval For Next Generation TRANBERG Laser Applicator
Brief: Clinical Laserthermia Systems AB To Utilize Loan Promise Of Sek 15 Million
Brief: Clinical Laserthermia Systems AB - Gets New Order
Brief: Clinical Laserthermia Systems Gets New Patent In EU
Brief: Clinical Laserthermia Systems Gets Order From Immunophotonics
Brief: Clinical Laserthermia Systems AB - Q3 Operating Loss Sek 8.3 Million
Brief: CLS Appoints Dan Mogren As Acting CEO
Brief: Clinical Laserthermia Gets CPT Reimbursement Code Approval
Brief: Clinical Laserthermia Systems Q2 Pretax Loss Widens To SEK 12.9 Mln
Brief: CLS And Advanced Medical Systems Start Collaboration
Brief: Clinical Laserthermia Systems Gets Patent In Japan
Brief: Clinical Laserthermia Systems Gets Order From Immunophotonics
Brief: CLS And Exact Imaging Renew Their MoU
Brief: Clinical Laserthermia Systems Q1 Pretax Loss At SEK 20.3 Mln
Brief: Clinical Laserthermia Systems Gets New Patent In USA
Brief: Clinical Laserthermia Systems Gets Order From University Hospital In Magdeburg, Germany